Bioscience

Biozona Weekly: Governor tours bio firms; TB drug development; Algae technology to ASU

February 13, 2014

By Flinn Foundation

Governor tours Oro Valley bioscience firms
2/12/14 | Arizona Daily Star | David Wichner

Gov. Jan Brewer visited Oro Valley to tour two of the area’s biggest biotech employers, Ventana Medical Systems/Roche and Sanofi, and meet with bioscience executives. Read also: Gov. Brewer meets with business leaders in Oro Valley, Tucson

Heliae algae technology headed to ASU
2/12/14 | Domesticfuel.com | Joanna Schroeder

Heliae’s algae production technology is heading to Arizona State University’s algae testbed facility, where the Gilbert-based company is partnering with SCHOTT North America to install a Helix photobioreactor.

Scottsdale’s Applied Biologics approved as government contractor
2/10/14 | Phoenix Business Journal | Angela Gonzales

Applied Biologics LLC, a Scottsdale biotech company using tissue from placentas to develop biologic products for health care providers, has been awarded a federal supply schedule contract.

Arizona, Sonora governors will recruit technology business in Israel
2/8/14 | Arizona Daily Star | Gabriela Rico

The governors of Arizona and Sonora, Mexico, will jointly travel to Israel to support an effort between the University of Arizona Tech Parks and The Offshore Group to recruit technology companies to the region with complementary resources on both sides of the border.

C-Path gets $11.8M grant to help TB drug development
2/4/14 | Arizona Daily Star | Staff Report

The Tucson-based Critical Path Institute has received a three-year, $11.8 million grant from the Bill & Melinda Gates Foundation to develop quantitative mathematical models to help design clinical trials for tuberculosis drugs.

Medtronic developing world’s smallest pacemaker in Tempe
2/4/14 | Phoenix Business Journal | Angela Gonzales

Medtronic Inc., the world’s largest medical device company, has begun worldwide trials of a pacemaker that’s one-tenth the size of a conventional pacemaker–or about the size of a vitamin–that was redesigned at the company’s Tempe research center.